PRESS RELEASE published on 02/28/2025 at 07:30, 1 year 8 months ago LR Health & Beauty SE achieves significant sales growth in the final quarter of 2024 and meets the sales and earnings forecast for the full year 2024 LR Health & Beauty SE reports significant sales growth of 8.0% in Q4 2024, reaching EUR 76.5 million. Full-year sales at EUR 289.2 million, meeting forecasts. Positive momentum from new products and realigned career plan Earnings Forecast Sales Growth LR Health & Beauty SE Product Launches Q4 2024
BRIEF published on 02/26/2025 at 15:35, 1 year 8 months ago LR Health & Beauty SE Seeks Nasdaq Stockholm Bond Listing Bond Prospectus Nasdaq Stockholm Financial Strategy Investor Information Corporate Bonds
BRIEF published on 02/26/2025 at 15:35, 1 year 8 months ago LR Health & Beauty SE cherche à s'introduire en bourse sur le Nasdaq Stockholm Stratégie Financière Nasdaq Stockholm Informations Pour Les Investisseurs Obligations D'entreprises Prospectus D'obligations
PRESS RELEASE published on 02/26/2025 at 15:30, 1 year 8 months ago LR Health & Beauty SE publishes bond prospectus and applies for admission to trading of bonds on the corporate bond list of Nasdaq Stockholm LR Health & Beauty SE publishes bond prospectus and applies for trading of bonds on Nasdaq Stockholm's corporate bond list; LR Group's holistic business model and commitment to sustainability showcased Sustainability Bond Prospectus Nasdaq Stockholm LR Health & Beauty LR Group
BRIEF published on 11/26/2024 at 12:52, 1 year 11 months ago LR Health & Beauty SE Sees Growth in Q3 2024 EBITDA Forecast LR Health & Beauty Third Quarter Growth 2024 Sales Increase Distributor Strategy
BRIEF published on 11/26/2024 at 12:52, 1 year 11 months ago LR Health & Beauty SE enregistre une croissance au troisième trimestre 2024 LR Santé & Beauté Croissance Au Troisième Trimestre Prévision De L'EBITDA Augmentation Des Ventes En 2024 Stratégie De Distribution
BRIEF published on 11/26/2024 at 12:50, 1 year 11 months ago LR Health & Beauty SE Adjusts 2024 Financial Forecasts Amid Sales Growth Financial Performance 2024 Forecast Adjustment Q3 Sales Growth EBITDA Changes Distributor Realignment
BRIEF published on 11/26/2024 at 12:50, 1 year 11 months ago LR Health & Beauty SE ajuste ses prévisions financières pour 2024 en raison de la croissance des ventes Performance Financière Croissance Des Ventes Au 3e Trimestre Ajustement Des Prévisions Pour 2024 Évolution De L'EBITDA Réalignement Des Distributeurs
PRESS RELEASE published on 11/26/2024 at 12:47, 1 year 11 months ago LR Health & Beauty SE further increases growth trend in the third quarter LR Health & Beauty SE reports 7.2% sales growth in Q3 2024, with EBITDA rising. LR ZEITGARD Signature boosts sales. Adjusted guidance for 2024: Sales range EUR 288M to EUR 292M, EBITDA EUR 26M to EUR 29M EBITDA Sales Growth Financial Forecast LR Health & Beauty SE LR ZEITGARD Signature
PRESS RELEASE published on 11/26/2024 at 12:45, 1 year 11 months ago EQS-Adhoc: LR Health & Beauty SE: Publication of figures for the third quarter of 2024 and adjustment of the forecast for the 2024 financial year LR Health & Beauty SE reports increase in sales for Q3 2024, adjusts forecast for full year. Sales guidance raised to EUR 288-292 million, EBITDA forecast revised to EUR 26-29 million Forecast Adjustment EBITDA Forecast Sales Increase LR Health & Beauty SE 2024 Financial Year
Published on 11/20/2026 at 13:30, 1 hour 5 minutes ago Collective Metals Enters Into Option to Acquire the Lac Tio West Property in Quebec
Published on 11/20/2026 at 13:30, 1 hour 5 minutes ago Alset AI Closes Non-Brokered Private Placement Offering
Published on 11/20/2026 at 02:00, 12 hours 35 minutes ago PPX Mining Announces Completion of Debt Settlement
Published on 11/19/2026 at 23:30, 15 hours 5 minutes ago EQ Inc. Reports Third Quarter 2026 Financial Results
Published on 11/20/2026 at 13:25, 1 hour 10 minutes ago TOP-REAL investigates whether digital monitoring can support earlier detection of toxicities and preserve continuity of one of the most effective treatments for HER2-positive metastatic breast cancer
Published on 11/20/2026 at 13:01, 1 hour 34 minutes ago Original-Research: Deutsche Rohstoff AG (von First Berlin Equity Research GmbH): Buy
Published on 11/20/2026 at 12:45, 1 hour 50 minutes ago Hong Kong showcases its unique advantages, forges closer ties with regional economies during APEC China 2026
Published on 11/20/2026 at 12:30, 2 hours 5 minutes ago Original-Research: Almonty Industries Inc (von GBC AG): BUY
Published on 11/20/2026 at 12:30, 2 hours 5 minutes ago HKSTP Debuts at MEDICA 2026, Forging Hong Kong-Europe Pathways for Life and Health Tech
Published on 11/19/2026 at 19:00, 19 hours 35 minutes ago MR.BRICOLAGE: OUTLOOK FOR THE 2026 FINANCIAL YEAR
Published on 11/19/2026 at 19:00, 19 hours 35 minutes ago MR.BRICOLAGE : PERSPECTIVES POUR L'EXERCICE 2026
Published on 11/19/2026 at 08:30, 1 day 6 hours ago Data sovereignty: Cegedim opens EB6, a next-generation datacenter for AI and high-density computing
Published on 11/19/2026 at 08:30, 1 day 6 hours ago Souveraineté des données : Cegedim ouvre EB6, un datacenter nouvelle génération pour l'IA et la haute densité